GreenAcre’s President criticized Florida’s current Medical Marijuana Program before the Florida House of Representatives.
On January 11th, 2017, the Health Quality Subcommittee of the Florida House of Representatives held the first meeting for 2017. The meeting entailed presentations and a panel discussion on Medical Cannabis. The panel discussion involved Christian Bax, Director of the Office of Compassionate Use, Florida Department of Health; Bertha Madras, PhD, Professor of Psychobiology, Harvard Medical School; and Sue Sisley, MD, Scottsdale Research Institute LLC.
At the end of the meeting, with less than 10 minutes, Representative Pigman opened the floor for public comments. Only 3 people gave public testimony, Mr. Rolando Vazquez, Esq., President of GreenAcre Consulting Team, was the last person to be recognized by the Committee, and the only person from Florida to give public testimony.
Mr. Rolando Vazquez, stated the following:
“There are some issues I see under the current Medical Marijuana Program. An issue of safety currently exists, those who have the ability to cultivate and process also have the ability to test their own product. There is clearly a conflict of interest here. Out of respect for patients and to error on the side of safety, this should not be allowed. There is also an issue with reliability, 7 suppliers in the State will not cover the demands under the new law. We have 20 million constituents. States with 5 million or less have hundreds to thousands of suppliers. The 7 suppliers simply will not cut it. There is also an issue with affordability, 7 suppliers for a State of 20 million constituents is tantamount to a monopoly. Under a monopoly you get high prices and poor quality. Florida needs to provide safe, reliable and affordable access to Medical Marijuana. My end point is that Florida needs to embrace an Open Market and those who cultivate and process should not be allowed to test their own material.”
Mr. Vazquez’s intentions are clear from his testimony. He is fighting for more cannabis licenses to become available. Moreover, those who secure licenses to cultivate, process and distribute should have no ability to test their own material. Ergo, the state of Florida needs to create separate licenses for lab testing facilities.
Sue Sisley, MD, Scottsdale Research Institute LLC and Rolando Vazquez, Esq., GreenAcre Consulting Team.